(Q34561031)

English

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Alexandre Urani

4

object named as

Alexandre Urani

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Philippe Pichat

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Olivier E Bergis

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jean-Paul Terranova

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Christine Duarte

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Vincent Santucci

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Christiane Gueudet

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Carole Voltz

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Régis Steinberg

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jeanne Stemmelin

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Florence Oury-Donat

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Patrick Avenet

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Bernard Scatton

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

0 references

publication date

23 August 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Neuropsychopharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

32

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

17-34

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301188

0 references

Schizophrenia, sensory gating, and nicotinic receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Neural systems underlying episodic memory: insights from animal research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Phencyclidine-induced psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

A synaptic model of memory: long-term potentiation in the hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Memory and schizophrenia: differential link of processing speed and selective attention with two levels of encoding.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Neuronal nicotinic receptor subtypes: defining therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Potential role of muscarinic receptors in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

The glutamatergic dysfunction hypothesis for schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Perseveration in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Absence of alpha7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Functional and anatomical aspects of prefrontal pathology in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Human neuronal nicotinic receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Hippocampal synaptic transmission enhanced by low concentrations of nicotine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Attentional effects of nicotinic agonists in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetize

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Cholinergic systems and schizophrenia: primary pathology or epiphenomena?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Serotonin-dopamine interaction and its relevance to schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Phencyclidine disrupts acquisition and retention performance within a spatial continuous recognition memory task.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Effects of ketamine in normal and schizophrenic volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Nicotinic treatment for cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Nicotinic acetylcholine involvement in cognitive function in animals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Impaired water maze navigation of Wistar rats with retrosplenial cortex lesions: effect of nonspatial pretraining

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Neuronal nicotinic receptors in the human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Historical perspective on CMS model.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Retrograde amnesia induced by drugs acting on different molecular systems.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Noradrenergic modulation of selective attention: its role in memory retrieval

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Reticular stimulation facilitates retrieval of a 'forgotten' maze habit.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl- d -aspartate receptor activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Smoking and cognitive deficits in schizophrenia: a pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Evidence for a dysfunctional retrosplenial cortex in patients with schizophrenia: a functional magnetic resonance imaging study with a semantic-perceptual contrast

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Blockade of phencyclidine-induced cortical apoptosis and deficits in prepulse inhibition by M40403, a superoxide dismutase mimetic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Chronic mild stress-induced anhedonia: a realistic animal model of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

21 January 2018

Normalization of auditory physiology by cigarette smoking in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

7 January 2021

based on heuristic

inferred from DOI database lookup

Episodic memory, amnesia, and the hippocampal-anterior thalamic axis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term memory for serial order in schizophrenia: a detailed examination of error types.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

7 January 2021

based on heuristic

inferred from DOI database lookup

Distress vocalization in rat pups. A simple screening method for anxiolytic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

7 January 2021

based on heuristic

inferred from DOI database lookup

AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

7 January 2021

based on heuristic

inferred from DOI database lookup

Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301188

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1301188

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16936709%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34561031&oldid=1526244707"